Hospitalization in Daily Home Hemodialysis and Matched Thrice-Weekly In-Center Hemodialysis Patients

被引:57
|
作者
Weinhandl, Eric D. [1 ]
Nieman, Kimberly M. [1 ]
Gilbertson, David T. [1 ]
Collins, Allan J. [1 ,2 ]
机构
[1] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
关键词
Hemodialysis; home hemodialysis (HHD); daily HHD; hospitalization; hospital admission; cardiovascular disease; infection; end-stage renal disease (ESRD); BUTTONHOLE CANNULATION; FREQUENT HEMODIALYSIS; SURVIVAL; OUTCOMES; STROKE; RISK;
D O I
10.1053/j.ajkd.2014.06.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular disease is a common cause of hospitalization in dialysis patients. Daily hemodialysis improves some parameters of cardiovascular function, but whether it associates with lower hospitalization risk is unclear. Study Design: Observational cohort study using US Renal Data System data. Setting & Participants: Medicare-enrolled daily (5 or 6 sessions weekly) home hemodialysis (HHD) patients initiating NxStage System One use from January 1, 2006, through December 31, 2009, and contemporary thrice-weekly in-center hemodialysis patients, matched 5 to 1. Predictor: Daily HHD or thrice-weekly in-center hemodialysis. Outcomes & Measurements: All-cause and cause-specific hospital admissions, hospital readmissions, and hospital days assessed from Medicare Part A claims. Results: For 3,480 daily HHD and 17,400 thrice-weekly in-center hemodialysis patients in intention-to-treat analysis, the HR of all-cause admission for daily HHD versus in-center hemodialysis was 1.01 (95% CI, 0.98-1.03). Cause-specific admission HRs were 0.89 (95% CI, 0.86-0.93) for cardiovascular disease, 1.18 (95% CI, 1.13-1.23) for infection, 1.01 (95% CI, 0.93-1.09) for vascular access dysfunction, and 1.02 (95% CI, 0.99-1.06) for other morbidity. Regarding cardiovascular disease, first admission and readmission HRs for daily HHD versus in-center hemodialysis were 0.91 and 0.87, respectively. Regarding infection, first admission and readmission HRs were 1.35 and 1.03, respectively. Protective associations of daily HHD with heart failure and hypertensive disease were most pronounced, as were adverse associations of daily HHD with bacteremia/sepsis, cardiac infection, osteomyelitis, and vascular access infection. Limitations: Results may be confounded by unmeasured factors, including vascular access type; information about dialysis frequency, duration, and dose was lacking; causes of admission may be misclassified; results may not apply to patients without Medicare coverage. Conclusions: All-cause hospitalization risk was similar in daily HHD and thrice-weekly in-center hemodialysis patients. However, risk of cardiovascular-related admission was lower with daily HHD, and risk of infection-related admission was higher. More attention should be afforded to infection in HHD patients. (C) 2014 by the National Kidney Foundation, Inc.
引用
收藏
页码:98 / 108
页数:11
相关论文
共 50 条
  • [21] Risk of intradialytic hypotension in patients on thrice-weekly versus twice-weekly hemodialysis
    Lei, Guangtao
    Li, Xia
    Tu, Weiping
    Xu, Chengyun
    Duan, Zibing
    Wu, Xianfeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 174 (03) : 821 - 823
  • [22] Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study
    Murea, Mariana
    Patel, Ashish
    Highland, Benjamin R.
    Yang, Wesley
    Fletcher, Alison J.
    Kalantar-Zadeh, Kamyar
    Dressler, Emily
    Russell, Gregory B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (02) : 227 - +
  • [23] In-Center Nocturnal Hemodialysis Performed Thrice-Weekly-A Provider's Perspective
    Lacson, Eduardo
    Diaz-Buxo, Jose
    SEMINARS IN DIALYSIS, 2011, 24 (06) : 668 - 673
  • [24] Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis
    Cheng, Yingzhang
    Tu, Weiping
    Xiao, Qingying
    Chen, Yan
    Hu, Lili
    Wu, Xianfeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 174 (03) : 780 - 783
  • [25] Home Hemodialysis: A Comparison of In-center and Home Hemodialysis Therapy in a Cohort of Successful Home Hemodialysis Patients
    Sands, Jeffrey J.
    Lacson, Eduardo, Jr.
    Ofsthun, Norma J.
    Kay, Janet C.
    Diaz-Buxo, Jose A.
    ASAIO JOURNAL, 2009, 55 (04) : 361 - 368
  • [26] Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients
    Tonelli, Marcello
    Wang, Wenjie
    Hemmelgarn, Brenda
    Lloyd, Anita
    Manns, Braden
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (06) : 1108 - 1115
  • [27] CHARACTERISTICS OF PATIENTS WHO TRANSITION BETWEEN TWICE-AND THRICE-WEEKLY HEMODIALYSIS
    Hur, Inkyong
    Obi, Yoshitsugu
    Streja, Elani
    Rhee, Connie
    Kalantar-Zadeh, Kam
    Kovesdy, Csaba
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 548 - 548
  • [28] Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis
    Rivara, Matthew B.
    Soohoo, Melissa
    Streja, Elani
    Molnar, Miklos Z.
    Rhee, Connie M.
    Cheung, Alfred K.
    Katz, Ronit
    Arah, Onyebuchi A.
    Nissenson, Allen R.
    Himmelfarb, Jonathan
    Kalantar-Zadeh, Kamyar
    Mehrotra, Rajnish
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (02): : 298 - 307
  • [29] Daptomycin Pharmacokinetics and Pharmacodynamics in a Pooled Sample of Patients Receiving Thrice-Weekly Hemodialysis
    Butterfield, Jill M.
    Mueller, Bruce A.
    Patel, Nimish
    Cardone, Katie E.
    Grabe, Darren W.
    Salama, Noha N.
    Lodise, Thomas P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (02) : 864 - 872
  • [30] COMPLIANCE IN HOME AND IN-CENTER HEMODIALYSIS-PATIENTS
    MCCOY, GC
    WITENBERG, SH
    BLANCHARD, LB
    MCGOLDRICK, MD
    CLINICAL RESEARCH, 1981, 29 (02): : A322 - A322